Pulmonary Aspergillosis
📧 Sign up to get email alerts when something new happens for Pulmonary Aspergillosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA) [Phase 1]
Phase 1 clinical trial evaluating inhaled liposomal amphotericin B deposition in individuals with chronic pulmonary aspergillosis; the study…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Vitamin D and Immune Response in Pulmonary Tuberculosis With and Without Chronic Pulmonary Aspergillosis
This ClinicalTrials.gov entry describes a study evaluating the effect of Vitamin D on immune response in pulmonary tuberculosis, with or wit…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome [NA]
This clinical trial is evaluating oral itraconazole alone versus itraconazole with systemic glucocorticoids in patients with Chronic Pulmona…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Prospective Observational Trial of IAPA
The clinical trial NCT04530799 is a prospective observational study of influenza-associated pulmonary aspergillosis (IAPA) and is currently …
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)
Clinical trial update noting that the study on COVID-19 associated pulmonary aspergillosis and other invasive fungal infections has complete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options [Phase 2]
Phase 2 clinical trial evaluating rezafungin for chronic pulmonary aspergillosis in adults with limited treatment options; currently recruit…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine [Phase 2]
Phase 2 clinical trial evaluating Gallium-68-deferoxamine for imaging in pulmonary aspergillosis, including chronic pulmonary aspergillosis …
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Pulmonary Aspergillosis in Tuberculosis Patients
A clinical trial update shows an active-not-recruiting study on pulmonary aspergillosis in patients with tuberculosis, examining overlap bet…
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
An ongoing Imperial College London clinical study is evaluating how chronic pulmonary aspergillosis impacts health status and patient well-b…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility Study [Phase 2]
This is a Phase 2 randomized feasibility trial evaluating interferon-gamma as adjunctive therapy for chronic pulmonary aspergillosis, curren…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Chronic Pulmonary Aspergillosis and Ambisome Aerosol with Itraconazole [Phase 3]
A Phase 3 clinical trial evaluating aerosolized amphotericin B liposomal (Ambisome) in combination with itraconazole for chronic pulmonary a…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis
ClinicalTrials.gov update on a voriconazole inhalation powder trial for pulmonary aspergillosis; the study is no longer available.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment [Phase 3]
Phase 3 study assessing ibrexafungerp in patients with invasive and mucocutaneous fungal diseases refractory to or intolerant of standard tr…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: A Safety Study of PC945 (Opelconazole) Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study) [Phase 2]
Phase 2 safety trial evaluating Opelconazole (PC945) for prophylaxis or pre-emptive therapy against pulmonary aspergillosis in lung transpla…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Uniportal VATS Resection for Pulmonary Aspergilloma : Evaluation of Prognostic Factors in a Single Center Experience [NA]
A completed single-center study evaluates uniportal video-assisted thoracoscopic resection for pulmonary aspergilloma and analyzes prognosti…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary Aspergillosis [Phase 3]
Phase 3 randomized trial comparing six months of oral itraconazole versus oral voriconazole for treatment-naïve chronic pulmonary aspergillo…
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: A Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Patients With Chronic Pulmonary Aspergillosis [Phase 3]
Phase 3 trial evaluating nebulized amphotericin B as maintenance therapy versus nebulized saline in chronic pulmonary aspergillosis is curre…
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Six Months Versus 12 Months of Oral Itraconazole Therapy for Management of Treatment naïve Subjects With CPA [Phase 3]
Phase 3 trial comparing six months versus twelve months of oral itraconazole for treatment-naïve chronic pulmonary aspergillosis.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic Fibrosis [Phase 4]
A Phase 4 clinical trial evaluating treatment for Aspergillus fumigatus infection in cystic fibrosis patients has completed, with results po…
-
CLINICAL_TRIALS research · 2017-01-20Clinical Trial Update: Aspergillus-specific IgG Assays for the Diagnosis of Chronic Pulmonary Aspergillosis (CPA)-Multicenter Study
A multicenter clinical trial evaluating Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis; current status…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Duplication in CHIT1 Gene and the Risk for Aspergillus Lung Disease in CF Patients
A completed clinical trial investigates whether duplication in the CHIT1 gene alters the risk of pulmonary aspergillosis in cystic fibrosis …
-
CLINICAL_TRIALS withdrawal · 2014-12-12Clinical Trial Update: Posaconazole as Salvage Therapy for Aspergillus Pulmonary Infection. [Phase 4]
A Phase 4 trial evaluating posaconazole as salvage therapy for pulmonary aspergillosis has been withdrawn.